CL2011000380A1 - Granulo para ser utilizado en la braquiterapia, que comprende una estructura insoluble o coloidal con radioisotopo, una matriz de polimero reabsorbible, que a su vez comprende particulas individuales, consistentes en sorbitol cubierto con un polimero biodegradable; y metodo para la fabricacion de dichos granulos. - Google Patents

Granulo para ser utilizado en la braquiterapia, que comprende una estructura insoluble o coloidal con radioisotopo, una matriz de polimero reabsorbible, que a su vez comprende particulas individuales, consistentes en sorbitol cubierto con un polimero biodegradable; y metodo para la fabricacion de dichos granulos.

Info

Publication number
CL2011000380A1
CL2011000380A1 CL2011000380A CL2011000380A CL2011000380A1 CL 2011000380 A1 CL2011000380 A1 CL 2011000380A1 CL 2011000380 A CL2011000380 A CL 2011000380A CL 2011000380 A CL2011000380 A CL 2011000380A CL 2011000380 A1 CL2011000380 A1 CL 2011000380A1
Authority
CL
Chile
Prior art keywords
insoluble
radioisotope
granule
brachytherapy
granules
Prior art date
Application number
CL2011000380A
Other languages
English (en)
Inventor
Darrell R Fisher
You Han Bae
Zhonggao Gao
Original Assignee
Batelle Memorial Institute Univ Of Utah Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/202,954 external-priority patent/US20100056843A1/en
Application filed by Batelle Memorial Institute Univ Of Utah Research Foundation filed Critical Batelle Memorial Institute Univ Of Utah Research Foundation
Publication of CL2011000380A1 publication Critical patent/CL2011000380A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/80—Component parts, details or accessories; Auxiliary operations
    • B29B7/88—Adding charges, i.e. additives
    • B29B7/94—Liquid charges
    • B29B7/945—Liquid charges involving coating particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/003—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/02—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
    • B29C43/027—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles having an axis of symmetry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966—Radiopaque markers visible in an X-ray image
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1024—Seeds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1087—Ions; Protons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1089—Electrons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B9/00—Making granules
    • B29B9/16—Auxiliary treatment of granules
    • B29B2009/163—Coating, i.e. applying a layer of liquid or solid material on the granule
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
    • B29K2067/04—Polyesters derived from hydroxycarboxylic acids
    • B29K2067/046—PLA, i.e. polylactic acid or polylactide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B29K2995/0059—Degradable
    • B29K2995/006—Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

EN LA PRESENTE INVENCIÓN SE PROVEE UN GRÁNULO PARA SER UTILIZADO EN LA BRAQUITERAPIA, QUE COMPRENDE UNA ESTRUCTURA INSOLUBLE O COLOIDAL QUE COMPRENDE UN RADIOISÓTOPO; UNA MATRIZ DE UN POLÍMERO REABSORBIBLE QUE TIENE LA ESTRUCTURA INSOLUBLE O COLOIDAL EN ELLA; Y DONDE LA MATRIZ DE UN POLÍMERO REABSORBIBLE COMPRENDE PARTÍCULAS INDIVIDUALES CONSISTENTES EN SORBITOL CUBIERTO CON POLÍMERO BIODEGRADABLE. LA INVENCIÓN PROVEE ADEMÁS UN MÉTODO PARA LA FABRICACIÓN DE GRÁNULOS PARA BRAQUITERAPIA QUE COMPRENDE LAS ETAPAS DE: PROVEER UNA ESTRUCTURA INSOLUBLE O COLOIDAL QUE COMPRENDE UN RADIOISÓTOPO; PROVEER UNA MEZCLA DE PARTÍCULAS, QUE SON PARTÍCULAS INDIVIDUALES QUE COMPRENDEN EN SORBITOL CUBIERTO CON POLÍMERO NATURAL; Y PRESIONAR LA MEZCLA DE PARTÍCULAS SOBRE LA ESTRUCTURA INSOLUBLE O COLOIDAL PARA FORMAR UN GRÁNULO DE BRAQUITERAPIA, EN DONDE EL GRÁNULO COMPRENDE LAS PARTÍCULAS QUE FORMAN UNA MATRIZ QUE COMPRENDE LA ESTRUCTURA INSOLUBLE O COLOIDAL.
CL2011000380A 2008-09-02 2011-02-22 Granulo para ser utilizado en la braquiterapia, que comprende una estructura insoluble o coloidal con radioisotopo, una matriz de polimero reabsorbible, que a su vez comprende particulas individuales, consistentes en sorbitol cubierto con un polimero biodegradable; y metodo para la fabricacion de dichos granulos. CL2011000380A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/202,954 US20100056843A1 (en) 2008-09-02 2008-09-02 Brachytherapy Seed With Fast Dissolving Matrix for Optimal Delivery of Radionuclides To Cancer Tissue
US12/552,190 US8821364B2 (en) 2008-09-02 2009-09-01 Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue

Publications (1)

Publication Number Publication Date
CL2011000380A1 true CL2011000380A1 (es) 2011-06-17

Family

ID=41319980

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000380A CL2011000380A1 (es) 2008-09-02 2011-02-22 Granulo para ser utilizado en la braquiterapia, que comprende una estructura insoluble o coloidal con radioisotopo, una matriz de polimero reabsorbible, que a su vez comprende particulas individuales, consistentes en sorbitol cubierto con un polimero biodegradable; y metodo para la fabricacion de dichos granulos.

Country Status (10)

Country Link
US (3) US8821364B2 (es)
EP (1) EP2331064B1 (es)
KR (1) KR101660061B1 (es)
CN (1) CN102202644A (es)
BR (1) BRPI0918594A2 (es)
CA (1) CA2733823C (es)
CL (1) CL2011000380A1 (es)
CO (1) CO6491121A2 (es)
MX (1) MX2011002095A (es)
WO (1) WO2010028048A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821364B2 (en) 2008-09-02 2014-09-02 Battelle Memorial Institute Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue
JP6106259B2 (ja) * 2012-03-21 2017-03-29 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 医用イメージングと生検データとを統合する臨床ワークステーション及びこれを使用する方法
GB2512384B (en) * 2013-03-28 2016-07-20 Elekta Ab Markers, Phantoms and Associated Methods for Calibrating Imaging Systems
CN103736200B (zh) * 2013-12-31 2016-08-17 原子高科股份有限公司 一种放射性粒子链的制备方法
CN104436248B (zh) * 2014-11-11 2016-12-21 成都维宁生物技术有限公司 装有放射性核素的微管及其制造方法及应用
DE102016119239A1 (de) * 2016-10-10 2018-04-12 Oncobeta International Gmbh Partikel und Zusammensetzung, die Rheniumverbindungen umfassen, und Prozesse zum Erhalten solcher Produkte
WO2018138744A1 (en) * 2017-01-24 2018-08-02 Maria Desantis Composition, device and method for conformational intra-tissue beta branchytherapy
MX2019013346A (es) * 2017-05-11 2020-01-20 Alpha Tau Medical Ltd Recubrimientos polimericos para dispositivos de braquiterapia.
EP3645058A4 (en) * 2017-06-28 2021-05-12 The Regents of The University of California COMPOSITE EMBOLIZATION BEADS
US10646727B2 (en) 2017-11-13 2020-05-12 Positive Energy, Llc Anchored brachytherapy device
CN108014414B (zh) * 2018-01-05 2019-10-18 清华大学 一种植入式可降解药物缓释电子贴片的制备方法
JP2021519126A (ja) 2018-04-02 2021-08-10 アルファ タウ メディカル リミテッド 放射性核種の管理された放出
CN110215600A (zh) * 2019-05-27 2019-09-10 北京大学第三医院 可携带放射粒子的植入物
US11478557B2 (en) * 2019-07-01 2022-10-25 Vivos, Inc. Method of preparing a radioactive yttrium phosphate particle suspension
JP2022547277A (ja) 2019-09-16 2022-11-11 エービーケー バイオメディカル インコーポレイテッド 放射性微粒子及び非放射性微粒子の組成物
CN111603575A (zh) * 2020-02-28 2020-09-01 彭盛 一种核壳结构的放射栓塞微球及其制备方法与应用
AU2021400142A1 (en) 2020-12-16 2023-06-22 Alpha Tau Medical Ltd. Diffusing alpha-emitters radiation therapy with enhanced beta treatment
US11964168B2 (en) 2021-06-10 2024-04-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for prostate cancer
WO2024052886A1 (en) * 2022-09-11 2024-03-14 Alpha Tau Medical Ltd. Radiotherapy sheet

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3041663A1 (de) 1980-11-05 1982-06-09 Buderus Ag, 6330 Wetzlar Verfahren und maschine zum innen- und aussenrundschleifen von werkstuecken
US6099457A (en) * 1990-08-13 2000-08-08 Endotech, Inc. Endocurietherapy
US6589502B1 (en) 1995-11-27 2003-07-08 International Brachytherapy S.A. Radioisotope dispersed in a matrix for brachytherapy
CA2248076A1 (en) 1996-03-11 1997-09-18 Richard D. Leavitt Polymeric delivery of radionuclides and radiopharmaceuticals
US7087244B2 (en) 2000-09-28 2006-08-08 Battelle Memorial Institute Thermogelling oligopeptide polymers
US6296831B1 (en) 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
US6841617B2 (en) 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
US20040228794A1 (en) 1998-04-10 2004-11-18 Battelle Memorial Institute Therapeutic agent carrier compositions
WO2000006243A2 (en) * 1998-07-28 2000-02-10 Innerdyne, Inc. Absorbable brachytherapy and chemotherapy delivery devices and methods
US7094765B1 (en) 1999-01-29 2006-08-22 Avi Biopharma, Inc. Antisense restenosis composition and method
DE60034317T2 (de) * 1999-02-25 2008-01-03 Ge Healthcare Ltd., Little Chalfont Medizinische instrumente und vorrichtungen mit verbesserter ultraschall-sichtbarkeit
US20020173451A1 (en) * 2000-10-24 2002-11-21 Sui-Long Yao Method of treating cancer
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc FLEXIBLE AND / OR ELASTIC BRACHYTHERAPY SEED OR STRAND
US6514193B2 (en) 2000-11-16 2003-02-04 Microspherix Llc Method of administering a therapeutically active substance
US7060020B2 (en) 2001-11-02 2006-06-13 Ideamatrix, Inc. Delivery system and method for interstitial radiation therapy
US6598502B1 (en) * 2002-01-28 2003-07-29 Titan Technologies International, Inc. Multi-swivel connector for a fluid operated tool
US7229973B2 (en) 2002-05-19 2007-06-12 You Han Bae pH-sensitive polymeric micelles for drug delivery
US7659314B2 (en) 2002-05-19 2010-02-09 University Of Utah Research Foundation PH-sensitive polymeric micelles for drug delivery
US20040197264A1 (en) 2003-04-04 2004-10-07 Alexander Schwarz Microspheres comprising therapeutic and diagnostic radioactive isotopes
US7371781B2 (en) 2003-09-22 2008-05-13 University Of Utah Research Foundation Tumor environment-induced ligand-expressing nanocarrier system
WO2005087274A1 (en) 2004-03-05 2005-09-22 Xl Sci-Tech, Inc. Particulate materials and compositions for radio therapy
US20080187998A1 (en) 2007-02-01 2008-08-07 University Of Utah Research Foundation Sulfonamide-based oligomers and polymers for destabilization of biological membranes
US8394391B2 (en) 2007-08-31 2013-03-12 University Of Utah Research Foundation Drug delivery vehicle that mimics viral properties
US8821364B2 (en) 2008-09-02 2014-09-02 Battelle Memorial Institute Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue

Also Published As

Publication number Publication date
CA2733823A1 (en) 2010-03-11
MX2011002095A (es) 2012-01-25
US8821364B2 (en) 2014-09-02
US9289625B2 (en) 2016-03-22
KR101660061B1 (ko) 2016-09-30
CN102202644A (zh) 2011-09-28
EP2331064A1 (en) 2011-06-15
KR20110054036A (ko) 2011-05-24
CA2733823C (en) 2015-02-17
CO6491121A2 (es) 2012-07-31
EP2331064B1 (en) 2013-08-28
US20100056844A1 (en) 2010-03-04
US20140350326A1 (en) 2014-11-27
WO2010028048A1 (en) 2010-03-11
BRPI0918594A2 (pt) 2018-01-30
US20160193479A1 (en) 2016-07-07

Similar Documents

Publication Publication Date Title
CL2011000380A1 (es) Granulo para ser utilizado en la braquiterapia, que comprende una estructura insoluble o coloidal con radioisotopo, una matriz de polimero reabsorbible, que a su vez comprende particulas individuales, consistentes en sorbitol cubierto con un polimero biodegradable; y metodo para la fabricacion de dichos granulos.
ES2541428T3 (es) Dispositivo para su uso en la manipulación de una carga y procedimiento para fabricar un dispositivo de este tipo
AR056341A1 (es) Material hibrido que se hincha en agua con adiivos inorganicos y metodo de producion del mismo
GT201200293A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
BRPI0510777A (pt) indazóis substituìdos, composições que os contêm, processo de produção e utilização
CO6592090A2 (es) Composicion fertilizante que contiene micronutrientes y metodos para elaborarla
BRPI1003281A2 (pt) Composição e método para maquilar um substrato queratínico
ATE488026T1 (de) Elektromagnetische strahlung emittierendes optoelektronisches bauelement und verfahren zur herstellung eines optoelektronischen bauelements
AR084330A1 (es) Polimeros a base de etileno y procesos para formarlos
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
CR7929A (es) Proceso para producir una preparacion recubierta
ECSP088356A (es) Pigmentos luminiscentes encapsulados
AR069252A1 (es) Metodos para el moldeado geomecanico de fracturas
AR112178A1 (es) Apuntalantes autosuspendibles mejorados hechos a partir de polímeros formados de hidrogeles en forma de polvo
EA201100047A1 (ru) Способ изготовления линзы для установки на светодиоде и линза, изготовленная таким способом
BRPI1002771A2 (pt) Composição e método para maquilar um substrato queratínico
AR096290A1 (es) Un agente de sostén
BR112013016445B8 (pt) método para fabricação de um conjunto dental
BR112012020491A2 (pt) processo para a preparação de forma alfa de mesilato de imatinib.
CL2017002659A1 (es) Marcadores genéticos asociados con la tolerancia a la sequía en el maíz (solicitud divisional de 1032-2015)
AR060060A1 (es) Recubrimiento transparente
PE20160601A1 (es) Metodo
AR074198A1 (es) Metodo para procesar datos medidos
AR096502A1 (es) Proceso para la producción de semilla granulada recubierta
BR112012027303A2 (pt) comprimido de desintegração oral contendo acarbose